Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy
- PMID: 2681539
- DOI: 10.1016/0022-510x(89)90157-3
Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy
Abstract
The localization of dystrophin was examined immunohistochemically in various tissues from mice and rats as well as from biopsied human muscle specimens, using polyclonal antibodies against dystrophin. Although dystrophin was completely absent in biopsied muscle specimens from 3 male DMD patients, it was faintly observed in the surface membrane of almost all muscle fibers examined in a female DMD patient. In all controls, human and animal, a strong dystrophin reaction was observed in the surface membrane of intrafusal muscle fibers and at the neuromuscular junctions, rather than in the surface membrane of skeletal and cardiac muscle fibers. In addition, dystrophin was clearly localized in the surface membrane of smooth muscle fibers in the viscera, bronchial system, ureter, and tunica media of blood vessels, including arteries and veins, in all examined animal tissues. In mdx mice, dystrophin was absent in almost all muscle and smooth muscle fibers in various tissues and blood vessels. These results suggested a possible systemic dysfunction of smooth muscle layers, especially those of blood vessels, as well as skeletal muscle fibers, due to a deficiency of dystrophin in Duchenne muscular dystrophy.
Similar articles
-
Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.Muscle Nerve. 1989 Dec;12(12):1009-16. doi: 10.1002/mus.880121209. Muscle Nerve. 1989. PMID: 2695839
-
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.Cell. 1988 Aug 12;54(4):447-52. doi: 10.1016/0092-8674(88)90065-7. Cell. 1988. PMID: 3042151
-
Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.Anat Rec. 1993 Apr;235(4):501-10. doi: 10.1002/ar.1092350403. Anat Rec. 1993. PMID: 8465985
-
Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy.Mol Cell Biol Hum Dis Ser. 1993;3:139-66. doi: 10.1007/978-94-011-1528-5_6. Mol Cell Biol Hum Dis Ser. 1993. PMID: 8111538 Review.
-
Unraveling the mysteries of Duchenne and Becker muscular dystrophy.Mol Chem Neuropathol. 1989 Feb;10(1):15-20. doi: 10.1007/BF02969482. Mol Chem Neuropathol. 1989. PMID: 2660836 Review.
Cited by
-
Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.PLoS Genet. 2019 Dec 26;15(12):e1008468. doi: 10.1371/journal.pgen.1008468. eCollection 2019 Dec. PLoS Genet. 2019. PMID: 31877123 Free PMC article.
-
Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies.Cells. 2019 Sep 11;8(9):1066. doi: 10.3390/cells8091066. Cells. 2019. PMID: 31514443 Free PMC article. Review.
-
Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells.Front Physiol. 2014 Feb 18;5:50. doi: 10.3389/fphys.2014.00050. eCollection 2014. Front Physiol. 2014. PMID: 24600399 Free PMC article. Review.
-
Dystrophin and a dystrophin-related protein in intrafusal muscle fibers, and neuromuscular and myotendinous junctions.Acta Neuropathol. 1992;84(2):141-6. doi: 10.1007/BF00311386. Acta Neuropathol. 1992. PMID: 1523969
-
Gastric emptying, small intestinal transit and fecal output in dystrophic (mdx) mice.J Physiol Sci. 2010 Jan;60(1):75-9. doi: 10.1007/s12576-009-0060-8. Epub 2009 Sep 26. J Physiol Sci. 2010. PMID: 19784719 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical